Estimates Revisions Karyopharm Therapeutics Inc. Boerse Muenchen
Stocks
25K0
US48576U2050
Pharmaceuticals
|
Market Closed -
Boerse Muenchen
16:44:02 2026-10-06 EDT
|
5-day change | 1st Jan Change | ||
| 0.5850 EUR | -3.31% |
|
-58.28% | - |
| 08-31 | Karyopharm Therapeutics Submits Supplemental New Drug Application to the Fda for Xpovio Plus Ruxolitinib for Patients with Myelofibrosis | CI |
| 08-29 | Karyopharm Therapeutics Inc. - Special Call |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Data source:
Karyopharm Therapeutics Inc.(KPTI)
EBIT - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
- Stock Market
- Stocks
- KPTI Stock
- 25K0 Stock
- Consensus Karyopharm Therapeutics Inc.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
